Recent filings by Sun Pharmaceutical Industries Limited

Published Title Summary
2025-03-10 17:05:25 Acquisition-XBRL SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange regarding Acquisition...
SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange regarding Acquisition
2025-01-17 14:30:42 Acquisition-XBRL Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition...
Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition
2025-01-16 18:42:56 Record Date Intimation under Regulation 42 of SEBI (Listing Obligations and Disclosure...
Intimation under Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Revision in Record Date
2025-01-16 13:34:38 Board Meeting Intimation SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board...
SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 31-Jan-2025 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended December 2024 and Dividend.
2024-10-09 14:08:08 Board Meeting Intimation SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board...
SUN PHARMACEUTICAL INDUSTRIES LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2024 .
2024-08-14 13:46:51 Acquisition-XBRL Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition...
Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition
2024-08-14 13:43:02 Acquisition Sun Pharmaceutical Industries Limited has informed the Exchange about Acquisition...
Sun Pharmaceutical Industries Limited has informed the Exchange about Acquisition
2024-05-22 15:32:23 Dividend Sun Pharmaceutical Industries Limited has informed the Exchange that Board...
Sun Pharmaceutical Industries Limited has informed the Exchange that Board of Directors at its meeting held on May 22, 2024, recommended Final Dividend of Rs. 5 per equity share.
2024-05-04 12:48:02 Acquisition-XBRL Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition...
Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition
2024-05-04 12:46:47 Acquisition-XBRL Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition...
Sun Pharmaceutical Industries Limited has informed the Exchange regarding Acquisition
2024-05-04 12:23:32 Acquisition Sun Pharmaceutical Industries Limited has informed the Exchange about Acquisition...
Sun Pharmaceutical Industries Limited has informed the Exchange about Acquisition